Honolulu, HI, United States of America

Mark T Hamann


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Honolulu, HI (US) (2000 - 2001)
  • Oxford, MS (US) (2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark T Hamann: Innovator in Pharmaceutical Compositions

Introduction

Mark T Hamann is a notable inventor based in Honolulu, Hawaii. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications. With a total of three patents to his name, Hamann's work focuses on innovative solutions for treating tumors and viral conditions.

Latest Patents

Hamann's latest patents include "Kahalalide F and compositions and uses thereof" and "Cytotoxic and antiviral compound." Both patents describe a compound that can be isolated from a sacoglossan, which may be utilized in the manufacture of pharmaceutical compositions. These compounds show promise in the treatment of tumors and viral conditions, highlighting Hamann's commitment to advancing medical science.

Career Highlights

Throughout his career, Mark T Hamann has been associated with Pharma Mar, S.A., a company known for its focus on marine-derived pharmaceuticals. His work has contributed to the understanding and development of new therapeutic agents, showcasing his expertise in the field.

Collaborations

Hamann has collaborated with esteemed colleagues such as Dolores Garcia Gravalos and Paul J Scheuer. These partnerships have further enriched his research and development efforts, leading to innovative breakthroughs in pharmaceutical applications.

Conclusion

Mark T Hamann stands out as a dedicated inventor whose work in pharmaceutical compositions has the potential to impact the treatment of serious health conditions. His innovative spirit and collaborative efforts continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…